NCT01608165 - A Feasibility Study for a Multicentre Randomised Controlled Trial to Compare Surgery With Needle Ablation Techniques in People With Small Renal Masses (4cm) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

January 31, 2015

Conditions

Renal Cancer

Interventions

PROCEDURE

Surgical treatment for renal mass

Patients will be randomised to receive a partial nephrectomy as treatment for their renal cancer mass

PROCEDURE

Percutaneous Radiofrequency ablation

Patients may be randomised to undergo a radiofrequency ablation treatment for their renal cancer mass

PROCEDURE

Laparascopic or percutaneous cryoablation

Patients may be randomised to undergo cryoablation as treatment for their renal cancer mass

Trial Locations (5)

South Mead Hospital, Bristol

Gartnavel Hospital, Glasgow

Guys and St Thomas Hospital, London

St George's Hospital, London

Freeman Hospital, Newcastle upon Tyne